Updates ·
Health notices · Thursday 22 October
3 notices from the agencies today, in plain words, each with the original linked.
FDA Class II recall for certain redness-relief eye drops
Food and Drug Administration (FDA) · Recall
If you used “Eye Drops MAXIMUM, REDNESS RELIEF, Sterile” (1/2 FL OZ/0.5 ML) or the related products listed in the notice, this affects you. The FDA says sterility means the product should not contain harmful germs.
This is a Class II recall, issued for a “Lack of Assurance of Sterility.” In plain terms, the eye drops may not be reliably sterile, which could increase risk of infection.
The notice lists distribution as US nationwide and was published on 2026-10-14. No specific instructions for patients were included in the notice you provided.
FDA class II recall for certain tirzepatide injection vials
FDA · Recall
If you use tirzepatide injection, this FDA notice may affect you if you have the specific product listed: Apothecary Pharma, LLC, 18mg/mL, 4 mL sterile multi-dose vial (Rx only; NDC 85091-001-18).
The FDA says there is a “lack of assurance of sterility,” meaning the product may not be reliably sterile.
The notice applies to distribution nationwide within the United States (published 2026-10-14).
No other patient instructions were included in the notice.
Some artificial tears eye drops may not be sterile
FDA · Recall
If you used these artificial tears sterile lubricant eye drops, there is a concern they may not be sterile.
This FDA notice covers specific product listings and says the issue was found for these drops despite being labeled as sterile.
If you have any, check whether your bottle matches the recalled product name and identifying details listed in the FDA notice.